LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Aurinia Pharmaceuticals Inc

Geschlossen

BrancheGesundheitswesen

8.18 1.36

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

8.08

Max

8.33

Schlüsselkennzahlen

By Trading Economics

Einkommen

22M

23M

Verkäufe

2.6M

62M

KGV

Branchendurchschnitt

29.482

51.198

EPS

0.16

Gewinnspanne

37.371

Angestellte

130

EBITDA

15M

22M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+20.52% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

31. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-53M

1.1B

Vorheriger Eröffnungskurs

6.82

Vorheriger Schlusskurs

8.18

Nachrichtenstimmung

By Acuity

50%

50%

167 / 380 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Aurinia Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Juni 2025, 20:45 UTC

Ergebnisse

Broadcom 2Q Sales Climb on Booming AI Demand

5. Juni 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5. Juni 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5. Juni 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5. Juni 2025, 21:32 UTC

Ergebnisse

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. Juni 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. Juni 2025, 20:45 UTC

Ergebnisse

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. Juni 2025, 20:24 UTC

Ergebnisse

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Rev $15B >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Net $4.97B >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Adj EPS $1.58 >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q EPS $1.03 >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom Sees 3Q Rev $15.8B >AVGO

5. Juni 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5. Juni 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5. Juni 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5. Juni 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5. Juni 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5. Juni 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5. Juni 2025, 18:26 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5. Juni 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5. Juni 2025, 16:30 UTC

Akquisitionen, Fusionen, Übernahmen

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5. Juni 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. Juni 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5. Juni 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5. Juni 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5. Juni 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5. Juni 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5. Juni 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Aurinia Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

20.52% Vorteil

12-Monats-Prognose

Durchschnitt 9.75 USD  20.52%

Hoch 11 USD

Tief 8 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Aurinia Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

4

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

8.1 / 8.21Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

167 / 380 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.